Pierre Michel Llorca, MD, PhD

This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article...

The relationship between insight and suicide in patients with schizophrenia is unclear. Read this article to learn the extent to which that relationship may be influenced by quality of...

Medication nonadherence among schizophrenia patients is common, but also possibly modifiable. Learn about how a patient self-report instrument—the MARS—can be used to identify nonadherence in these patients.